VBIV – VBI Vaccines Inc.
Float Short %
1.04
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
0.51
EPS Last/This Y
4.8
EPS This/Next Y
0.95
Price
0.06
Target Price
5
Analyst Recom
2
Performance Q
-89.15
Relative Volume
Beta
2.18
Ticker: VBIV
19 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-11-17 | VBIV | 0.0653 | N/A | N/A | 0 |
| 2025-11-18 | VBIV | 0.0653 | N/A | N/A | 0 |
| 2025-11-19 | VBIV | 0.0653 | N/A | N/A | 0 |
| 2025-11-20 | VBIV | 0.0653 | N/A | N/A | 0 |
| 2025-11-21 | VBIV | 0.0653 | N/A | N/A | 0 |
| 2025-11-24 | VBIV | 0.0653 | N/A | N/A | 0 |
| 2025-11-25 | VBIV | 0.0653 | N/A | N/A | 0 |
| 2025-11-26 | VBIV | 0.0653 | N/A | N/A | 0 |
| 2025-12-01 | VBIV | 0.0653 | N/A | N/A | 0 |
| 2025-12-02 | VBIV | 0.0653 | N/A | N/A | 0 |
| 2025-12-03 | VBIV | 0.0653 | N/A | N/A | 0 |
| 2025-12-04 | VBIV | 0.0653 | N/A | N/A | 0 |
| 2025-12-05 | VBIV | 0.0653 | N/A | N/A | 0 |
| 2025-12-08 | VBIV | 0.0653 | N/A | N/A | 0 |
| 2025-12-09 | VBIV | 0.0653 | N/A | N/A | 0 |
| 2025-12-10 | VBIV | 0.0653 | N/A | N/A | 0 |
| 2025-12-11 | VBIV | 0.0653 | N/A | N/A | 0 |
| 2025-12-12 | VBIV | 0.0653 | N/A | N/A | 0 |
| 2025-12-15 | VBIV | 0.0653 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
19 items
«
‹
Current Page1 of 1
›
»
No data found
No data found
[stock_market_widget type="chart" template="candlestick" assets="VBIV" range="1y" interval="1d" price_field="close" heading="{symbol}" candle_border_width="1" candle_bullish_background_color="#21BA45" candle_bearish_background_color="#DB2828" candle_bullish_border_color="#21BA45" candle_bearish_border_color="#DB2828" axes_color="#000000" tooltip_text_color="#262626" tooltip_background_color="#ffffff" range_selector="true" volume_enabled="true" axes_enabled="true" tooltip_enabled="false" zoom_enabled="true" save_image_enabled="true" volume_bar_fill_color="#5679FF" api="yahoo-finance"]
Last Quarter Act. EPS
-0.73
Avg. EPS Est. Current Quarter
-0.32
Avg. EPS Est. Next Quarter
-0.22
Insider Transactions
Institutional Transactions
Beta
2.18
Average Sales Estimate Current Quarter
3
Average Sales Estimate Next Quarter
3
Fair Value
Quality Score
6
Growth Score
61
Sentiment Score
21
Actual DrawDown %
100
Max Drawdown 5-Year %
-100
Target Price
5
P/E
Forward P/E
PEG
P/S
0.2
P/B
P/Free Cash Flow
EPS
-3.54
Average EPS Est. Cur. Y
-1.23
EPS Next Y. (Est.)
-0.28
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
Return on Equity vs Sector %
1512.9
Return on Equity vs Industry %
1484.7
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
[stock_market_widget type=”table-options” template=”gradient” color=”#5679FF” assets=”VBIV” fields=”contract_symbol,type,strike,price,change_pct,implied_volatility,change_abs,open_interest,volume,in_the_money,bid,ask” pagination=”true” rows_per_page=”21″ sort_direction=”asc” alignment=”left” search=”true” sort_field=”strike” api=”yahoo-finance”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”VBIV” options_type=”calls” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”VBIV” options_type=”puts” x_axis_field=”strike” y_axis_field=”price” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”VBIV” options_type=”calls” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”VBIV” options_type=”puts” x_axis_field=”strike” y_axis_field=”implied_volatility” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”VBIV” options_type=”calls” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
[stock_market_widget type=”chart-options” template=”basic” color=”#5679FF” assets=”VBIV” options_type=”puts” x_axis_field=”strike” y_axis_field=”volume” axes=”true” cursor=”true” display_currency_symbol=”true” api=”yf”]
Sector: Healthcare
Industry: Biotechnology
Employees: 131
VBI Vaccines Inc., a commercial-stage biopharmaceutical company, develops and sells vaccines to treat immuno-oncology and infectious disease. It offers hepatitis B (HBV) vaccine under the PreHevbrio, PreHevbri, and Sci-B-Vac brand names. The company also develops VBI-2601, a protein based immunotherapeutic candidate for the treatment of chronic HBV infection; VBI-1901, a glioblastoma cancer vaccine immunotherapeutic candidate; VBI-1501, a prophylactic cytomegalovirus vaccine candidate; and VBI-2501 to treat Zika virus. In addition, it develops coronavirus vaccine candidates that include VBI-2902, VBI-2901, and VBI-2905. The company has collaboration and license agreements with Brii Biosciences Limited, the National Research Council of Canada, and Coalition for Epidemic Preparedness Innovations. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is based in Cambridge, Massachusetts.
stock quote shares VBIV – VBI Vaccines Inc. Stock Price stock today
news today VBIV – VBI Vaccines Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch VBIV – VBI Vaccines Inc. yahoo finance google finance
stock history VBIV – VBI Vaccines Inc. invest stock market
stock prices VBIV premarket after hours
ticker VBIV fair value insiders trading